Stocks and Investing Stocks and Investing
Fri, October 25, 2019
Thu, October 24, 2019

Gena Wang Maintained (BMRN) at Hold with Decreased Target to $86 on, Oct 24th, 2019


Published on 2024-10-26 17:19:34 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Decreased Target from $95 to $86 on, Oct 24th, 2019.

Gena, nor any peers, have made any analyst calls on BMRN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources